Weight loss injections can help people lose more weight than with other methods of weight loss, including lifestyle changes ...

In patients with obesity, tirzepatide improved cardiometabolic parameters and risk for cardiovascular disease, but the ...

In a striking new study, the anti-obesity drug tirzepatide, known as Mounjaro and Zepbound, not only triggered significant ...

Postmenopausal women on tirzepatide show lower weight loss than those typically seen with the obesity drug, but weight loss ...

Concurrent use of menopausal hormone therapy may augment the weight loss benefits of tirzepatide for postmenopausal women ...

A large network meta-analysis ranked eight GLP-1 receptor agonists for glycemic, weight, and safety outcomes in adults with ...

A weight loss drug has been found to dramatically reduce breast cancer tumour growth while still achieving significant weight ...

A head-to-head trial found that tirzepatide led to significantly greater weight loss and waist reduction than semaglutide in adults with obesity but without diabetes. Over 72 weeks, tirzepatide ...

An earlier trial of tirzepatide showed weight loss of between about 15% and about 22% of body weight, or about 35 pounds to about 52 pounds, depending on the dose. The drugs appear effective for ...

Over 90% achieved ≥ 5% weight loss, irrespective of BMI and tirzepatide dose, ... Cite this: 'Staggering' Weight Loss and Benefits in Body Composition With Tirzepatide - Medscape - May 19, 2023.

All doses of tirzepatide, a medication approved in the EU to treat type 2 diabetes and obesity, consistently reduced body weight in women and men, but women experienced greater weight loss ...

Tirzepatide, the main ingredient in the weight loss drug Zepbound (shown here), may also offer benefits to patients who have a common heart failure condition.